Digital Health Global

FEBRUARY 9, 2024

From the world of artificial intelligence and machine learning to the expanding horizons of telehealth, wearable health technologies, data security, and digital therapies, each trend represents a significant step in the journey toward a more efficient, personalized, and accessible healthcare system.

Mental health 167

Mental health Pharmaceuticals Telemedicine Health Technology 167

Lloyd Price

NOVEMBER 6, 2023

The impact of digital health: Digital health technologies are transforming the way healthcare is delivered. The conference is likely to feature discussions on the latest digital health trends, as well as the impact of digital health on the pharmaceutical industry and the overall healthcare system.

Pharmaceuticals 60

Pharmaceuticals Digital Health healthcare technology Leadership 60

Lloyd Price

SEPTEMBER 12, 2023

The growth of the NGBGM market is expected to drive M&A activity in the healthtech sub sector in 2024. Companies that are developing new NGBGM technologies or that are looking to expand their reach in the market are expected to be active in M&A deals. The company is likely to be a target for acquisition by a larger company.

Pharmaceuticals 64

Pharmaceuticals Interoperability Digital Health Health IT 64

DrKumo Remote Patient Monitoring

FEBRUARY 4, 2024

The 2024 Medicare Physician Fee Schedule (PFS) Final Rule, set forth by the Centers for Medicare & Medicaid Services (CMS), brings pivotal updates in healthcare reimbursement. The conversion factor for 2024 has been adjusted to $32.7375, a decrease from the 2023 conversion factor of $33.8872.

Medicare 40

Medicare Telehealth Mental health Digital Health 40

Healthcare IT Today

APRIL 5, 2024

Kinsa’s innovative approach to early warning and predictive analytics complements Healthy Together’s commitment to leverage technology for the greater good. This acquisition reinforces Healthy Together’s commitment to driving positive change in public health outcomes. Originally announced March 5th, 2024

Public Health 70

Public Health Pharmaceuticals Health Technology Healthcare IT 70

Digital Health Global

APRIL 5, 2024

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% growth between 2023 to 2024. hike over 2022, with more than 6,100 molecules in active development. Overall R&D expenditure totals about $276.81 billion, with a slow 2.5%

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

JANUARY 22, 2024

“Now, with Dr. Abu-Nuwar championing our technology at Abdali Hospital and the support of one of our lead investors, Hikma Ventures (the strategic venture capital arm of Hikma Pharmaceuticals PLC ), we are able to deliver intelligent information to doctors beyond the U.S. to reduce surgical complication rates.

Pharmaceuticals 88

Pharmaceuticals Digital Health Healthcare Innovation Health Technology 88